Stonepine Capital Management, LLC 13D and 13G filings for Aprea Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-13 12:15 pm Sale |
2024-12-31 | 13G | Aprea Therapeutics, Inc. APRE |
Stonepine Capital Management, LLC | 286,395 5.100% |
-79,041 (-21.63%) |
Filing |
| 2024-10-10 4:07 pm Purchase |
2024-10-07 | 13G | Aprea Therapeutics, Inc. APRE |
Stonepine Capital Management, LLC | 365,436 6.600% |
365,436 (New Position) |
Filing |